Crowdonomics
WatchlistPortfolio
REGENMED

Reg CF · Class B Non-Voting Common Stock · Oct 2024

ClosedReached targetReg CFCommon Equity
via StartEngine · last checked Oct 4, 2026View campaign
Raised
$258.5K / $1.2M max
21% of ceiling · target hit day 17
Investors
38
$6.8K avg
Post-money valuation
$20.3M
pre-money + amount raised

Raised over time

Cumulative raisedInvestors
$259K$130K$0
38190
Oct 1, 2024 · openedOct 22, 2025 · last reading
Target ($15K) hit — Oct 18, 2024, day 17Deadline Dec 30, 2024

Left axis: cumulative dollars raised. Right axis: cumulative investors. Live figures via StartEngine, last checked Oct 4, 2026; investor counts may lag the platform by up to a day.

Financials disclosed in this offering

FY2022–FY2023 · hover for source
$63K
−$891K
FY2022
$97K
−$1.1M
FY2023
RevenueNet income
Metric
FY2022 reviewed
FY2023 reviewed
Income statement
Revenue
$63,382
$96,500
Cost of goods sold
$0
$0
Gross margin
100%
100%
Net income
-$890,958
-$1,093,806
Taxes paid
$0
$0
Balance sheet
Cash
$99,203
$60,817
Accounts receivable
$0
$0
Total assets
$1,388,899
$1,265,684
Short-term debt
$9,420
$0
Long-term debt
$837,263
$1,615,000
Total liabilities
$846,683
$1,615,000
Other
Headcount
—
1

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Amendments to this offering

4 amendments
  1. Feb 7, 2025
    • Deadline Apr 30, 2025 → Mar 6, 2025closing early

    “Issuer is moving up end date to March 6th, 2025.”

    Form C/A on EDGAR ↗
  2. Jan 28, 2025
    • Deadline Mar 3, 2025 → Apr 30, 2025

    “Issuer is disclosing the appointment of Dolph Courchaine and extending their campaign end date to April 30th, 2025.”

    Form C/A on EDGAR ↗
  3. Dec 18, 2024
    • Deadline Dec 30, 2024 → Mar 3, 2025

    “Issuer is extending their campaign to March 3rd, 2025.”

    Form C/A on EDGAR ↗
  4. Oct 2, 2024
    No change to filed terms

    “Administrative correction to Issuer state address.”

    Form C/A on EDGAR ↗

Each line compares the amendment with the previous filing of this offering. The quoted reason is the issuer’s own statement from the Form C/A.

Deal terms

Pre-money$20M
Post-money$20.3M
Price / share$9.60
Shares offered1,562

Perks

Invest $1,000+ and receive 2% bonus shares2% bonus$1K+

Offering details

Target$14,995
Max$1,234,982
Min investment$336
OpenedOct 1, 2024
DeadlineDec 30, 2024
Days active738

Links & provenance

Campaign pagePitch videoSEC filing
Source: SEC EDGAR
0001665160-24-001365
Last synced Aug 18, 2026

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.